• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Ahmedabad, Nov. 4 Merck & Co Inc’s local affiliate, MSD Pharmaceuticals (India), launched Gardasil, a vaccine for cervical cancer caused by HPV types 6, 11, 16 and 18.

“In line with our commitment to putting patients first, MSD India will work with partners and communities to enhance awareness for the disease and access for the vaccine,” said Dr Naveen A. Rao, Managing Director, MSD India.

According to the 2008 recommendations of the Indian Academy of Pediatrics’ Committee on Immunization, “This vaccine has a favourable tolerability profile and the IAP-COI recommends offering HPV vaccine to all females as per label. The recommended age for initiation of vaccination is 10 to 12 years and catch-up vaccination is permitted up to the age of 26 years. It is recommended to be given in three doses at 0, 2 and 6 months.”

More Stories on : New Products & Services | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line